Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model

Other recent posts

Blog

Human Challenge Studies: Their Conduct and Safety Aspects

If there would be a survey of 100 clinical research professionals either from CRO or from Pharma/Biotech industry to explain what a human challenge study is, the most common answer...

Read more

Article

Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial

View Link

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.